Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,39 USD | -3,14% | -1,74% | -16,91% |
01/04 | ASPIRA WOMEN'S HEALTH INC. : Cantor Fitzgerald vindt het aandeel niet inspirerend | ZM |
28/03 | Transcript : Aspira Women's Health Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Omzet 2024 * | 10,96 mln. 10,25 mln. | Omzet 2025 * | 19,67 mln. 18,39 mln. | Marktkapitalisatie | 41,85 mln. 39,11 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -17 mln. -15,89 mln. | Nettowinst (verlies) 2025 * | -15 mln. -14,02 mln. | EV/omzet 2024 * | 3,82 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 2,13 x |
K/w-verhouding 2024 * |
-2,52
x | K/w-verhouding 2025 * |
-3,28
x | Werknemers | 64 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 61,16% |
Recentste transcriptie over Aspira Women's Health Inc.
1 dag | -3,14% | ||
1 week | -1,74% | ||
Lopende maand | +9,35% | ||
1 maand | -7,12% | ||
3 maanden | -22,95% | ||
6 maanden | -36,28% | ||
Lopend jaar | -16,91% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nicole Sandford
CEO | Chief Executive Officer | 54 | 22-02-21 |
Sandra Milligan
PSD | President | - | 01/04 |
Torsten Hombeck
DFI | Director of Finance/CFO | 54 | 15-06-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ellen Vos
BRD | Director/Board Member | 68 | 09-05-23 |
Director/Board Member | 58 | 09-05-23 | |
Jannie Herchuk
CHM | Chairman | 61 | 09-05-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 3,39 | -3,14% | 7 829 |
22-04-24 | 3,5 | +0,29% | 5 397 |
19-04-24 | 3,49 | -1,13% | 6 952 |
18-04-24 | 3,53 | +1,15% | 7 831 |
17-04-24 | 3,49 | +1,16% | 13 727 |
uitgestelde koers Nasdaq, 23 april 2024 om 22:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-16,91% | 41,85 mln. | |
-14,13% | 11,53 mld. | |
+45,76% | 3,31 mld. | |
-35,86% | 2,11 mld. | |
-18,27% | 2,05 mld. | |
-27,92% | 1,49 mld. | |
+18,02% | 1,02 mld. | |
-3,49% | 741 mln. | |
-31,42% | 426 mln. | |
+26,64% | 372 mln. |